BiotechTube
Actinia

Actinia

San Diego, United States· Est.
actiniadetectors.com
Is this your company? Claim your profile to update info and connect with investors.
Claim profile

Private Company

Funding information not available

Overview

Actinia is a private, pre-revenue biotechnology company commercializing novel halide perovskite semiconductor materials for radiation detection. Its flagship material, CsPbBr3 (CLB), has demonstrated record-breaking energy resolution for gamma-ray and X-ray detection, promising to double imaging resolution or halve patient dose in modalities like SPECT and CT. Spun out from Northwestern University with backing from Kairos Ventures, Actinia is positioned to disrupt the medical imaging and nuclear security markets with its foundational materials science IP.

OncologyCardiology

Technology Platform

Halide perovskite semiconductor crystals (e.g., CsPbBr3) for direct-conversion radiation detection, enabling high energy resolution at room temperature.

Opportunities

The global push for lower-dose, higher-resolution medical imaging creates a strong tailwind for Actinia's technology, allowing OEMs to differentiate next-generation scanners.
In nuclear security, the need for portable, high-performance detectors for infrastructure monitoring and non-proliferation offers a significant government-driven market.

Risk Factors

Key risks include the challenge of scaling production of high-quality perovskite crystals consistently and cost-effectively, and the long commercialization cycle required to convince established medical device and security OEMs to adopt a novel detector material.
Competition from incremental improvements in existing technologies also persists.

Competitive Landscape

Actinia competes with established radiation detector materials like cadmium zinc telluride (CZT), scintillators coupled to photomultipliers, and high-purity germanium (HPGe). Its value proposition is superior energy resolution at room temperature compared to CZT and scintillators, and operational simplicity (no cryogenics) compared to HPGe. It faces competition from other startups and academic groups also exploring perovskites and other novel semiconductors.

More companies in Diagnostics & Precision Medicine →More companies in United States →